Product Description
AMONDYS 45 is used to treat patients with Duchenne muscular dystrophy (DMD) who have a confirmed mutation of the dystrophin gene that can be treated by skipping exon 45.
This indication is approved under accelerated approval based on an increase in dystrophin production in skeletal muscle observed in patients treated with AMONDYS 45. Continued approval for this indication may be contingent upon verification of a clinical benefit in confirmatory trials.
How to use
Your doctor or nurse will give you this medicine. Kindly do not self administer.
Side Effects
- upper respiratory tract infection
- cough
- fever
- headache
- joint pain
- mouth and throat pain
- ear pain
- ear infection
Storage
Store in a refrigerator (2 - 8°C). Do not freeze.℃
0.0
0 Reviews